Cencora, Inc. cotiza a 330.11 USD y tiene una capitalización bursátil de $63.0B. En los últimos 12 meses ha facturado $332.8B con un margen de flujo de caja libre del 1.0%. Cotiza a 15.5 veces su flujo de caja libre (P/FCF) y a un PER de 24.0. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hos…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $4.48 | $4.75 | $4.08 |
| Estimado | $4.57 | $4.35 | $4.72 | $4.04 |
| Sorpresa | — | +3.0% | +0.6% | +1.0% |
| Métrica | COR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 3.6% | 57.0% | -53.5% |
| Operating Margin | 0.8% | -38.6% | +39.4% |
| Net Margin | 0.5% | -33.6% | +34.0% |
| FCF Margin | 1.0% | -13.9% | +14.9% |
| ROE | 103.1% | -40.4% | +143.5% |
| ROA | 2.0% | -32.0% | +34.0% |
| Current Ratio | 0.90 | 2.84 | -1.94 |
| Debt / Equity | 5.08 | 0.28 | +4.80 |